NARATRIPTAN STADA HEMOFARM 2.5mg film-coated tablets medication leaflet

N02CC02 naratriptan • Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists

Naratriptanum is a medication used for the treatment of acute migraine, with or without aura. It belongs to the class of serotonin receptor agonists (triptans) and works by constricting dilated blood vessels in the brain, reducing pain and other migraine-associated symptoms.

The medication is taken orally, usually in tablet form, and is effective in providing rapid relief from migraine symptoms. It is intended for occasional use and should not be used for migraine prevention.

Side effects may include nausea, dizziness, fatigue, or a sensation of pressure in the chest. In rare cases, severe reactions such as high blood pressure or cardiac ischemia may occur.

Consult your doctor before use, especially if you have cardiovascular conditions or are taking other medications. Use Naratriptanum as directed to avoid complications.

General data about NARATRIPTAN STADA HEMOFARM 2.5mg

Substance: naratriptan

Date of last drug list: 01-07-2013

Commercial code: W56650007

Concentration: 2.5mg

Pharmaceutical form: film-coated tablets

Quantity: 24

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: CENTRAFARM SERVICES BV - OLANDA

Holder: STADA HEMOFARM S.R.L. - ROMANIA

Number: 7929/2015/07

Shelf life: 4 years